Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

ClinicalTrials.gov ID: NCT01609140

Public ClinicalTrials.gov record NCT01609140. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Placebo-Controlled, Double-Blind Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and cholesterol lowering effects of MPSK3169A when given as subcutaneous (SC) injections over a 24-week period to patients with a high risk of cardiovascular events and LDL-c levels well above goal.

Study identification

NCT ID
NCT01609140
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
248 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2012 (Type not available)
Primary completion
May 2013 (Actual)
Completion
Jul 2013 (Actual)
Last update posted
Nov 2, 2016

2012 – 2013

United States locations

U.S. sites
34
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Not listed Goodyear Arizona 85395 —
Not listed Carmichael California 95608 —
Not listed Spring Valley California 91978 —
Not listed Walnut Creek California 94598 —
Not listed Wildomar California 92595 —
Not listed Jacksonville Florida 32216 —
Not listed Ponte Verde Florida 32081 —
Not listed Boise Idaho 83704 —
Not listed Indianapolis Indiana 46260 —
Not listed Iowa City Iowa 52242 —
Not listed Auburn Maine 04210 —
Not listed Baltimore Maryland 21209 —
Not listed Bethesda Maryland 20817 —
Not listed St Louis Missouri 63110 —
Not listed Rochester New York 14609 —
Not listed Wilmington North Carolina 28401 —
Not listed Fargo North Dakota 58103 —
Not listed Cincinnati Ohio 45212 —
Not listed Cincinnati Ohio 45219 —
Not listed Springdale Ohio 45246 —
Not listed Oklahoma City Oklahoma 73103 —
Not listed Tulsa Oklahoma 74136 —
Not listed Greer South Carolina 29650 —
Not listed Mt. Pleasant South Carolina 29464 —
Not listed Spartanburg South Carolina 29303 —
Not listed Rapid City South Dakota 57701 —
Not listed Bristol Tennessee 37620 —
Not listed Knoxville Tennessee 27912 —
Not listed Boerne Texas 78006 —
Not listed Dallas Texas 75230 —
Not listed Dallas Texas 75231 —
Not listed Houston Texas 77030 —
Not listed Richmond Virginia 23294 —
Not listed Wenatchee Washington 98801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01609140, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2016 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01609140 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →